Skip to main content

Advertisement

ADVERTISEMENT

Conference Coverage

Conference Coverage
10/14/2022
At the 2022 Oncology Clinical Pathways Congress, Mary M. Ichiuji, MD, Kaiser Permanente and National Physician Lead, Beacon Oncology, presented the development of Kaiser Permanente Beacon Oncology Module EPIC, a patient-centered,...
At the 2022 Oncology Clinical Pathways Congress, Mary M. Ichiuji, MD, Kaiser Permanente and National Physician Lead, Beacon Oncology, presented the development of Kaiser Permanente Beacon Oncology Module EPIC, a patient-centered,...
At the 2022 Oncology Clinical...
10/14/2022
Journal of Clinical Pathways
Conference Coverage
10/14/2022
At the 2022 Oncology Clinical Pathway Congress, Rebecca Miksad, MD, MPH, Flatiron Health; and Carole Tremonti, RN, MBA, Three Mountains LLC, presented how population-level data provides specificity and creates value in aiding decision-making.
At the 2022 Oncology Clinical Pathway Congress, Rebecca Miksad, MD, MPH, Flatiron Health; and Carole Tremonti, RN, MBA, Three Mountains LLC, presented how population-level data provides specificity and creates value in aiding decision-making.
At the 2022 Oncology Clinical...
10/14/2022
Journal of Clinical Pathways
Conference Coverage
10/01/2022
At least a quarter of patients at Memorial Sloan Kettering Cancer Center suffer with financial difficulties related to cancer treatment, suggesting a need for systems-based interventions to proactively assess financial toxicity risk and refer...
At least a quarter of patients at Memorial Sloan Kettering Cancer Center suffer with financial difficulties related to cancer treatment, suggesting a need for systems-based interventions to proactively assess financial toxicity risk and refer...
At least a quarter of patients...
10/01/2022
Journal of Clinical Pathways

Advertisement

Conference Coverage
10/01/2022
At the 2022 ASCO Quality Care Symposium, Ives and colleagues concluded that therapeutic interchange is an effective way to reduce total cost of care while maintaining the quality of care in the Oncology Care Model.
At the 2022 ASCO Quality Care Symposium, Ives and colleagues concluded that therapeutic interchange is an effective way to reduce total cost of care while maintaining the quality of care in the Oncology Care Model.
At the 2022 ASCO Quality Care...
10/01/2022
Journal of Clinical Pathways
Conference Coverage
09/30/2022
Clinical outcomes from a multi-institutional study analyzing patient outcomes following inpatient immune checkpoint inhibitor therapy may “give clinicians pause” when considering inpatient immune checkpoint inhibitor use, according to a study...
Clinical outcomes from a multi-institutional study analyzing patient outcomes following inpatient immune checkpoint inhibitor therapy may “give clinicians pause” when considering inpatient immune checkpoint inhibitor use, according to a study...
Clinical outcomes from a...
09/30/2022
Journal of Clinical Pathways
Conference Coverage
09/30/2022
Pathway compliance was observed in almost two-thirds of cases among patients with metastatic disease who were treated in the first-line setting, according to a presentation at the 2022 ASCO Quality Care Symposium. Due to increasing health...
Pathway compliance was observed in almost two-thirds of cases among patients with metastatic disease who were treated in the first-line setting, according to a presentation at the 2022 ASCO Quality Care Symposium. Due to increasing health...
Pathway compliance was observed...
09/30/2022
Journal of Clinical Pathways

Advertisement

Conference Coverage
09/30/2022
Cancer-patient navigation programs tend to reduce total costs of care and improve outcomes. This study, presented at the 2022 ASCO Quality Care Symposium, explored whether an independent cancer-patient navigation program in collaboration with...
Cancer-patient navigation programs tend to reduce total costs of care and improve outcomes. This study, presented at the 2022 ASCO Quality Care Symposium, explored whether an independent cancer-patient navigation program in collaboration with...
Cancer-patient navigation...
09/30/2022
Journal of Clinical Pathways
Conference Coverage
09/30/2022
While the total number of new therapy starts in multiple myeloma (MM) decreased during COVID-19, the rate of new starts for both intravenous and oral therapies in MM significantly increased, according to study findings presented at the 2022...
While the total number of new therapy starts in multiple myeloma (MM) decreased during COVID-19, the rate of new starts for both intravenous and oral therapies in MM significantly increased, according to study findings presented at the 2022...
While the total number of new...
09/30/2022
Journal of Clinical Pathways
Conference Coverage
09/30/2022
Randomized controlled trials at academic medical centers have shown an improvement in clinical outcomes when utilizing patient-reported outcome-based symptom management solutions, according to a presentation at the 2022 ASCO Quality Care...
Randomized controlled trials at academic medical centers have shown an improvement in clinical outcomes when utilizing patient-reported outcome-based symptom management solutions, according to a presentation at the 2022 ASCO Quality Care...
Randomized controlled trials at...
09/30/2022
Journal of Clinical Pathways

Advertisement

Conference Coverage
09/30/2022
Traditional frailty indices are not widely utilized in clinical oncology. According to a presentation at the 2022 ASCO Quality Care Symposium, an EFI created from electronic medical records can be utilized as an objective, standardized...
Traditional frailty indices are not widely utilized in clinical oncology. According to a presentation at the 2022 ASCO Quality Care Symposium, an EFI created from electronic medical records can be utilized as an objective, standardized...
Traditional frailty indices are...
09/30/2022
Journal of Clinical Pathways

Advertisement